Global Veterinary Digital Pathology Market 2034 Forecast

Global Veterinary Digital Pathology Market Growth, Size, Trends Analysis- By Product, By Animal Type, By Application, By End Use – Regional Outlook, Competitive Strategies and Segment Forecast to 2034

Published: Jan-2026 Report ID: HLCA2607 Pages: 1 - 221 Formats*:     
Category : Healthcare
According to SPER Market Research, the Global Veterinary Digital Pathology Market is estimated to reach USD 1792.47 million by 2034 with a CAGR 15.45%.

Introduction and Overview
The report includes an in-depth analysis of the global veterinary digital pathology market, including market size and trends, product mix, applications, and supplier analysis. 

The global veterinary digital pathology market was valued at USD 426.1 million in 2024 and is expected to grow at a CAGR of around 15.45% from 2025 to 2034, reaching approximately USD XX billion by 2034. The market is witnessing strong growth driven by rising demand for fast, accurate, and efficient disease diagnosis in animals. Increasing cases of chronic conditions such as cancer, along with infectious diseases in both companion and livestock animals, are pushing veterinarians to adopt advanced diagnostic technologies. Compared to conventional methods, digital pathology offers greater efficiency through high-resolution imaging, rapid analysis, and reduced error rates, enabling quicker and more reliable diagnoses. Features such as faster turnaround times, improved accuracy, and limited human intervention are accelerating adoption. Additionally, the integration of AI and machine learning enhances automated imaging, pattern recognition, and predictive diagnostics, further supporting market expansion.

By Product:
Based on product type, the global market is segmented into whole slide imaging systems, image analysis software, and storage and communication systems. Among these, whole slide imaging systems hold the dominant market position due to their widespread adoption in veterinary clinics and pathology laboratories. These systems convert glass slides into high-resolution digital images, enabling faster, more accurate evaluations and efficient case reviews. Features such as automated scanning, batch processing, and seamless integration with laboratory and practice management software reduce manual workload and improve workflow efficiency. Ongoing technological advancements, increasing digitization, and growing investments in veterinary healthcare infrastructure continue to support strong demand for these systems.

By animal type:
Based on animal type, the global veterinary digital pathology market is segmented into companion animals, livestock animals, and wildlife and exotic animals. Companion animals, including dogs, cats, horses, and other pets, accounted for the largest market share in 2024. This dominance is driven by the growing adoption of pets worldwide and rising expenditure on animal healthcare. Dogs and cats represent a significant portion of household pets, contributing to higher diagnostic demand. Additionally, the increasing prevalence of chronic diseases such as cancer among companion animals has heightened the need for accurate and early diagnosis, thereby accelerating the adoption of veterinary digital pathology solutions.

By Application:
Based on application, the global veterinary digital pathology market is divided into diagnosis and research, with the diagnosis segment leading in recent years and expected to grow strongly over the forecast period. Rising incidences of zoonotic infections, metabolic disorders, and complex pathological conditions in animals are driving demand for advanced diagnostic solutions. Digital pathology replaces manual interpretation with automated and standardized workflows, reducing subjectivity and enabling high-throughput analysis of biopsy and cytology samples. Expanding veterinary practices and increasing cancer cases in companion animals further boost adoption, as digital pathology supports early tumor detection, accurate grading, and improved treatment outcomes.

Regional Insights:
North America led the global veterinary digital pathology market in 2024, supported by strong growth in the U.S. driven by increasing government funding, investments in animal health infrastructure, and active involvement of agencies such as the USDA and NIH. High pet ownership, advanced veterinary services, a robust livestock industry, and rising animal healthcare spending further support market expansion. The growing prevalence of chronic diseases and demand for early, accurate diagnosis are accelerating adoption. Meanwhile, Europe also represents a significant market, fueled by rising pet adoption, supportive government initiatives, technological advancements, and the strong presence of key players developing AI-enabled and cloud-based diagnostic solutions.

Market Competitive Landscape:
The veterinary digital pathology market is highly consolidated. Some of the market key players are 3DHistech, Agfa-Gevaert, Aiforia Technologies, Antech Diagnostics, IDEXX Laboratories, Indica Labs, Leica Biosystems (Danaher), Motic, Proscia, Sakura Finetek USA, Scopio Labs, VCA, and Zoetis.

Recent Developments:
In February 2025, Torigen Pharmaceuticals collaborated with Proscia to deploy the Concentriq digital pathology platform in veterinary oncology. The platform enables quicker and more accurate diagnoses for pets while supporting the development of personalized immunotherapies. This partnership strengthened Proscia’s presence and expanded its reach within the veterinary digital pathology market.

In December 2024, Zoetis introduced Vetscan OptiCell, a cartridge-based, AI-enabled hematology analyzer developed to provide advanced complete blood count analysis. The product launch strengthened Zoetis’ existing business portfolio and enhanced its overall diagnostic capabilities.

Scope of the report:

Report MetricDetails
Market size available for years2021-2034
Base year considered2024
Forecast period2025-2034
Segments coveredBy Product, By Animal Type, By Application, By End Use
Regions coveredNorth America, Latin America, Asia-Pacific,  Europe, and Middle East and Africa
Companies Covered3DHistech, Agfa-Gevaert, Aiforia Technologies, Antech Diagnostics, IDEXX Laboratories, Indica Labs, Leica Biosystems (Danaher), Motic, Proscia, Sakura Finetek USA, Scopio Labs, VCA, and Zoetis.

Key Topics Covered in the Report
  • Global Veterinary Digital Pathology Market Size (FY’2021–FY’2034)
  • Overview of Global Veterinary Digital Pathology Market
  • Segmentation of Global Veterinary Digital Pathology Market by Product (Whole slide imaging systems, Image analysis software, Storage and communication systems)
  • Segmentation of Global Veterinary Digital Pathology Market by Animal Type (Companion Animals, Livestock animals, Wildlife and exotic animals)
  • Segmentation of Global Veterinary Digital Pathology Market by Application (Diagnosis, Research)
  • Segmentation of Global Veterinary Digital Pathology Market by End Use (Veterinary hospitals and clinics, Veterinary diagnostic labs, Academic and research institutes, and Other end use)
  • Statistical Snap of Global Veterinary Digital Pathology Market
  • Expansion Analysis of Global Veterinary Digital Pathology Market
  • Problems and Obstacles in Global Veterinary Digital Pathology Market
  • Competitive Landscape in the Global Veterinary Digital Pathology Market
  • Details on Current Investment in Global Veterinary Digital Pathology Market
  • Competitive Analysis of Global Veterinary Digital Pathology Market
  • Prominent Players in the Global Veterinary Digital Pathology Market
  • SWOT Analysis of Global Veterinary Digital Pathology Market
  • Global Veterinary Digital Pathology Market Future Outlook and Projections (FY '2025–FY '2034)
  • Recommendations from the analyst

1. Introduction
1.1. Scope of the report
1.2. Market segment analysis 

2. Research Methodology
2.1. Research data source
2.1.1. Secondary Data
2.1.2. Primary Data
2.1.3. SPER’s internal database
2.1.4. Premium insight from KOL’s
2.2. Market size estimation
2.2.1. Top-down and Bottom-up approach
2.3. Data triangulation

3. Executive Summary

4. Market Dynamics
4.1. Driver, Restraint, Opportunity and Challenges analysis
4.1.1. Drivers
4.1.2. Restraints
4.1.3. Opportunities
4.1.4. Challenges

5. Market variable and outlook
5.1. SWOT Analysis
5.1.1. Strengths
5.1.2. Weaknesses
5.1.3. Opportunities
5.1.4. Threats
5.2. PESTEL Analysis
5.2.1. Political Landscape
5.2.2. Economic Landscape
5.2.3. Social Landscape
5.2.4. Technological Landscape
5.2.5. Environmental Landscape
5.2.6. Legal Landscape
5.3. PORTER’s Five Forces 
5.3.1. Bargaining power of suppliers
5.3.2. Bargaining power of buyers
5.3.3. Threat of Substitute
5.3.4. Threat of new entrant
5.3.5. Competitive rivalry
5.4. Heat Map Analysis

6. Competitive Landscape
6.1. Global Veterinary Digital Pathology Market Manufacturing Base Distribution, Sales Area, Product Type 
6.2. Mergers & Acquisitions, Partnerships, Product Launch, and Collaboration in Global Veterinary Digital Pathology Market


7. Global Cloud Telecommunications AI Market, By Product, (USD Million) 2021-2034 
7.1. Whole slide imaging systems
7.2. Image analysis software
7.3. Storage and communication systems

8. Global Cloud Telecommunications AI Market, By Animal Type, (USD Million) 2021-2034 
8.1. Companion animals  
8.1.1. Dogs
8.1.2. Cats
8.1.3. Horses
8.1.4. Other companion animals 
8.2. Livestock animals    
8.2.1. Cattle
8.2.2. Swine
8.2.3. Poultry
8.2.4. Other livestock animals
8.3. Wildlife and exotic animals

9. Global Cloud Telecommunications AI Market, By Application, (USD Million) 2021-2034 
9.1. Diagnosis
9.2. Research

10. Global Cloud Telecommunications AI Market, By End Use, (USD Million) 2021-2034 
10.1. Veterinary hospitals and clinics
10.2. Veterinary diagnostic labs
10.3. Academic and research institute
10.4. Other end use

11. Global Veterinary Digital Pathology Market, (USD Million) 2021-2034 
11.1. Global Veterinary Digital Pathology Market Size and Market Share

12. Global Veterinary Digital Pathology Market, By Region, 2021-2034 (USD Million)
12.1. Asia-Pacific
12.1.1. Australia
12.1.2. China
12.1.3. India
12.1.4. Japan
12.1.5. South Korea
12.1.6. Rest of Asia-Pacific
12.2. Europe
12.2.1. France
12.2.2. Germany
12.2.3. Italy
12.2.4. Spain
12.2.5. United Kingdom
12.2.6. Rest of Europe
12.3. Middle East and Africa
12.3.1. Kingdom of Saudi Arabia 
12.3.2. United Arab Emirates
12.3.3. Qatar
12.3.4. South Africa
12.3.5. Egypt
12.3.6. Morocco
12.3.7. Nigeria
12.3.8. Rest of Middle-East and Africa
12.4. North America
12.4.1. Canada
12.4.2. Mexico
12.4.3. United States
12.5. Latin America
12.5.1. Argentina
12.5.2. Brazil
12.5.3. Rest of Latin America 

13. Company Profile
13.1. 3DHistech
13.1.1. Company details
13.1.2. Financial outlook
13.1.3. Product summary 
13.1.4. Recent developments
13.2. Agfa-Gevaert
13.2.1. Company details
13.2.2. Financial outlook
13.2.3. Product summary 
13.2.4. Recent developments
13.3. Aiforia Technologies
13.3.1. Company details
13.3.2. Financial outlook
13.3.3. Product summary 
13.3.4. Recent developments
13.4. Antech Diagnostics
13.4.1. Company details
13.4.2. Financial outlook
13.4.3. Product summary 
13.4.4. Recent developments
13.5. IDEXX Laboratories
13.5.1. Company details
13.5.2. Financial outlook
13.5.3. Product summary 
13.5.4. Recent developments
13.6. Indica Labs
13.6.1. Company details
13.6.2. Financial outlook
13.6.3. Product summary 
13.6.4. Recent developments
13.7. Leica Biosystems (Danaher)
13.7.1. Company details
13.7.2. Financial outlook
13.7.3. Product summary 
13.7.4. Recent developments
13.8. Motic
13.8.1. Company details
13.8.2. Financial outlook
13.8.3. Product summary 
13.8.4. Recent developments
13.9. Proscia
13.9.1. Company details
13.9.2. Financial outlook
13.9.3. Product summary 
13.9.4. Recent developments
13.10. Sakura Finetek USA
13.10.1. Company details
13.10.2. Financial outlook
13.10.3. Product summary 
13.10.4. Recent developments
13.11. Scopio Labs
13.11.1. Company details
13.11.2. Financial outlook
13.11.3. Product summary 
13.11.4. Recent developments
13.12. VCA
13.12.1. Company details
13.12.2. Financial outlook
13.12.3. Product summary 
13.12.4. Recent developments
13.13. Zoetis
13.13.1. Company details
13.13.2. Financial outlook
13.13.3. Product summary 
13.13.4. Recent developments
13.14. Others

14. Conclusion

15. List of Abbreviations

16. Reference Links

SPER Market Research’s methodology uses great emphasis on primary research to ensure that the market intelligence insights are up to date, reliable and accurate. Primary interviews are done with players involved in each phase of a supply chain to analyze the market forecasting. The secondary research method is used to help you fully understand how the future markets and the spending patterns look likes.

The report is based on in-depth qualitative and quantitative analysis of the Product Market. The quantitative analysis involves the application of various projection and sampling techniques. The qualitative analysis involves primary interviews, surveys, and vendor briefings.  The data gathered as a result of these processes are validated through experts opinion. Our research methodology entails an ideal mixture of primary and secondary initiatives.

SPER-Methodology-1

SPER-Methodology-2

SPER-Methodology-3


Frequently Asked Questions About This Report
PLACE AN ORDER
  • 15 % off
     
    $ 4250
  • 20 % off
             
    $ 5650
  • 25 % off
         
    $ 7450
Pre-Purchase Inquiry
SEND AN INQUIRY
NEED CUSTOMIZATION?
Request Customization
CALL OR EMAIL US
US:
India:
Email:
100% Secure Payment

SPER American Express
SPER VISA
SPER Master Card
SPER Mestro
SPER Paypal
SPER CCAvenues

Have a glance of the Report

  Download Free Sample

Looking for Customization?

 Customization Request

Have a Question?

 Reach Our Analysis Team

COVID-19 impact analysis?

 Request Analysis
Thought Leadership

Trusted by Industry Leaders

Our data-driven insights have influenced the strategy of 200+ reputed companies across the globe.

SPER-Astellas Pharma
SPER-Microsoft
SPER-EY
SPER-McKinsey
SPER-Bain
SPER-Max-Healthcare
SPER-DHL
SPER-IQVIA
SPER-Mitsubishi Logistics
SPER-PACCOR
SPER-Macmillan Education
SPER-Kankar IMRB
SPER-ITA
SPER-PWC
SPER-SAPTCA
SPER-Straumann
SPER-Danaher
SPER-AandM
SPER-MENARINI Silicon Biosystems
SPER-IPSOS
SPER-Heineken
HIPPA Compliant
GDPR Certified
ISO 27001
Peer Reviewed
Get Started Today

Your Competitive Advantage in
Pharmaceutical & Medical Technology
Markets

Join industry leaders leveraging AI-powered intelligence to make confident, data-driven decisions that accelerate breakthrough treatments and technologies to market.

No Credit Card Required
15-Minute Demo
Expert Guidance